How Timing of Chemotherapy After SCLC Diagnosis Affects Survival

The timing of chemotherapy given to patients with small cell lung cancer (SCLC) does not have a statistically significant effect on OS, said Faruk Tas and colleagues, despite previous research showing that a delay of treatment may lead to adverse patient outcomes.


DocWire Content Partners

Powered by DocWire News

The Latest From GI Oncology Now

The Latest From Heme Today

Expert Interviews

Network Websites